CONTOX DRUG SCREEN CONTROL— 510(k) K830494

Substantially Equivalent

Kaulson Laboratories, Inc.

FDA 510(k) clearance K830494 for CONTOX DRUG SCREEN CONTROL, Substantially Equivalent on 1983-03-11. Applicant: Kaulson Laboratories, Inc..

Clearance details

Applicant: Kaulson Laboratories, Inc.
Product code: Code DIF
Advisory panel: Clinical Toxicology
Date received: 1983-02-16
Decision date: 1983-03-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.